Chapter 185:

"The production rights of erlotinib. If you are so concerned about the production of international original research drugs, you should know about erlotinib. I will authorize its production rights to Xiangkun Second Factory, but you must know that erlotinib is the first This cancer-targeted drug, his attention is very high, and the quality control of the drug must meet the requirements of the international drug market."
"Drug production subcontracting rights, you can give it to whomever you like. You can, like those foreign pharmaceutical companies, require sincerity money, bidding, and high profits." Li Zheng said with a smile, as if to say something. A trivial matter.
Li Zhiqiang stood there in a daze, earnest money, bidding, and high profit sharing. He fantasized in his dreams countless times that he wanted foreigners to taste these sufferings, but now that the illusion is about to come true, he is not happy at all.
He felt as if he was stepping on the cloud. Although he was standing high, he stepped on a soft cloud. He didn't know when it would fall.
Before he could figure out why, he was surrounded by a group of people and walked downstairs, with "buzzing" voices in his ears. Some said congratulations, and some said that he was a blessing in disguise.
The people on the rooftop left one after another. Only Li Zheng was left. Liang Zhe's mouth was pressed into a straight line and never let go. Professor Yang looked like hesitating and stopping.
A smile came up at the corner of Li Zheng's mouth. He slowly walked to the edge of the roof. As soon as he approached, he felt his right hand was being pulled by a strong force. He turned his head and looked at Liang Zhe.
Liang Zhe held his arm tightly, "Dangerous." He whispered.
Li Zheng laughed, "Don't worry, I cherish my life." He said, and took two steps forward. Looking down from the rooftop, he just saw Li Zhiqiang and others who came downstairs being caught by the media. Surrounded.
The interview car with the CTV logo is particularly conspicuous in the afternoon sun. Yes, it's windy...
"Let's go." Li Zheng turned his head and said to the two.
The group of three walked downstairs. On the way, Old Yang couldn't help but speak: "Li Zheng, don't take this matter to heart. We are not saints who can do everything."
Old Yang could see that Li Zheng was a little concerned about Li Zhiqiang's accusations.
Li Zheng's footsteps paused, and a trace of warmth flashed in his eyes, "Don't worry, Professor Yang, I know it in my heart."
If according to later generations, Li Zhiqiang's words on the rooftop are completely moral kidnapping, Li Zheng is naturally clear. However, it is a fact that Li Zheng is close to foreign pharmaceutical companies. Li Zhiqiang will think so, and others will think so. This is a time bomb, and if it is not detonated, it will always be a hidden danger.
Now that Li Zhiqiang has detonated the bomb in this way, it is not a completely bad thing for Li Zheng. After all, how good his performance today is, humbly admits his mistakes, knows his mistakes, can correct it, right.
Moreover, Li Zhiqiang can be regarded as lovely compared to those who were kidnapped by morals in later generations. After all, he has such a respectable sense of responsibility in his heart, which is why Li Zheng gave him the right to produce erlotinib without hesitation.
For Li Zheng, the patentee, whoever produces the drug is not the production. If this can promote the development of domestic drug manufacturing, that would be great.
No matter how powerful Li Zheng is, he is only one person. It is difficult for him to bring up an industry alone. A complete pharmaceutical industry, from the laboratory to the hands of each patient, needs to undergo research and development, approval, production, and sales.
There are specializations in the surgery industry, and some things are better left to professionals.
This building was already in trouble, and there were so many pedestrians coming and going. The police and firefighters had surrounded it for so long, and the incident could not be suppressed at all.
However, both large and small newspapers in Huajing reported the incident.
However, most of these newspapers reported the incident from the aspect of corruption. Only Xinghua News Agency took a different approach until the nature of the incident strongly criticized China's current drug approval system.
At the same time, an interview abroad caused an uproar among the senior officials in China.
This is a dialogue between a well-known anchor who has interviewed Hua Guo and a pharmaceutical company executive.
"I know that there is a saying in the pharmaceutical industry that the source of life of a pharmaceutical company is research and development, it is the laboratory, and its throat is the sales channel. Today we will talk about the throat and sales channel of the pharmaceutical company."
"Director Carter, I think you, an expert, should be able to talk."
"Of course, I am honored to have a conversation with your famous host, Mr. Hector."
"As for sales channels, the reason why world-renowned pharmaceutical companies, including our Merck & Co., Ltd., can occupy more than 80% of the international drug market, apart from our strong research and development capabilities, huge drug patent library, and The important thing is our sales channels."
"We have the largest sales channels. A pharmaceutical company has invested huge capital, manpower and material resources. When a drug is finally available, the first thing we need to do is to bring it to the market as soon as possible, and then Profit back to capital."
"And from the launch of R&D to sales, there is still a link."
"FDA?" Hector was speaking.
"Yes, it's like we have an FDA in the United States, and other countries in the world have similar drug regulatory systems that approve market access for drugs that enter their domestic sales."
"This is responsible for the health of the residents of this country. This is what it should be," Hector said.
"Yes, but there are tricks in it." Carter made a mysterious expression.
Hector laughed. "Director Carter, you don't want to sell it."
"Okay, let me give you an example. For example, Catanstein, which just went on the market a while ago, was approved by the FDA only last month, but this drug has been produced in our Merck production workshop for four years. Why? This is caused by the different drug approval systems in different countries."
"Some countries, such as the United States, and developed countries such as European countries, have strict drug approval systems. Every drug on the market requires very strict clinical trials. But some countries are different, and some countries only need to submit clinical trial reports. Some require that drugs that have been reviewed in other countries can be directly marketed in their country." Carter said with a smile.
Hector rubbed the stubble on his chin with his right hand, and said thoughtfully: "If it is a medicine, it has been approved in countries that only need to submit clinical trial reports. Does it mean that it can be used in many countries? Simultaneous listing?"
"Mr. Hector, you deserve to be Mr. Hector. That's right, that’s it, which means that in many countries, we save the manpower and material resources to conduct drug clinical trials again. Although this drug approval system is implemented, most For countries that are relatively backward, getting their officials to sign the market access approval may require a considerable amount of expense. However, this expense is not worth mentioning compared to the benefits of drugs entering the market a year earlier."
Hector let out a sigh of admiration, "What if there is a problem with the drug? The first country to sign the market access approval, its national reputation..."
"In fact, for a drug that can be clinically tested in the laboratory, the probability of a problem is very low. But if there is a problem, of course, it will have an impact on the national credibility of that country."
Zhu Xin stepped forward, took out the video tape, and then looked at the person sitting on the conference table behind him slightly.
"Leaders, this is brought back by the employees of our Xinghua News Agency in the United States, and it is also the reason why we write this report from an institutional perspective."
The meeting room was very quiet. Zhu Xin could almost hear his high-speed heart beating. As the editor-in-chief of Xinghua News Agency, he was considered a ministerial cadre at the administrative level. I have never seen so many leaders at once.
The old people at the conference table looked solemn, and the conversation between Hector and Carter hit the two most sensitive points in their hearts, the credibility of the country and the sense of responsibility for the health of the people.
After a long time, the old man sitting in the center said: "Xiao Zhu, go out first and leave the video tape."
"Okay, leader." Zhu Xin said hurriedly.
Walking out of the conference room, he let out a long sigh of relief, wiped the non-existent beads of sweat on his forehead, and walked out quickly.
"Professor Li, Professor Li, it's true that a new born calf is not afraid of tigers, and it made me a middle-aged person."
When receiving a call from Zhu Xin, Li Zheng happened to be reading a paper. In the middle of last year, Science magazine sent an invitation letter to Li Zheng, inviting him to be a journal reviewer, and Li Zheng agreed.
No, reading a paper is considered work.
"Li Zheng, I have handed you the video tapes and reports. This system change is not so easy. Take your advice." Zhu Xin's voice came from the other end of the phone.
"Okay, thank you, Editor-in-Chief Zhu." Li Zheng said this, and drew a tick in the column of "Preparation for Public Opinion" in the schedule.
After hanging up Zhu Xin's call, Li Zheng stood up from his seat, "Have you found your partner?"
Liang Zhe has not been free for the past few days. He leaves early and returns late every day, and occasionally comes back with the smell of alcohol.
Li Zheng thought he was a very good-tempered partner, but he still felt a little uncomfortable in his heart.
"Well, it's probably confirmed. A second-generation military family from the Northeast, the background is neither deep nor shallow, just right." Liang Zhe paused, "I want to have dinner with them at night, and I might come back later."
"Kacha." The pen in Li Zheng's hand broke.
"Late? How late?"
"Probably... ten o'clock." Liang Zhe's intuition has always been very accurate. He looked up at Li Zheng's expression and saw that he seemed to be the same as before. He hesitated for a moment or changed his words: "Nine o'clock, I'll be back at nine o'clock. "